novartis glp 1 drug Novo Nordisk asks FDA not to allow GLP-1 compounding The GLP-1 Revolution: From Diabetes
Description
Wei-Tong-Xin exerts anti-inflammatory effects through TLR4-mediated macrophages M1/M2 polarization and affects GLP-1 secretion
An effective diabetes drug The latest study included people with prediabetes
Multiple sclerosis GLP-1 receptor agonists show neuroprotective properties that extend to autoimmune conditions of the central nervous system
doi: 10.1016/S1262-3636(17)30067-8
N Engl J Med 2024;390:1394-407
